# A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

> **NCT00457626** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 66 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT00457626
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-09
- **Primary completion:** 2009-05-25
- **Final completion:** 2009-05-25
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457626, "A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00457626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*